Director/PDMR Shareholding
Source: RNS
Hikma Pharmaceuticals PLC - EIP Vesting
LONDON, 20 May 2020: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 16 May 2018 under the 2014 Executive Incentive Plan ("EIP") Element B which was completed on 19 May 2020.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Mazen Darwazah
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Mazen Darwazah |
2 |
Reason for the notification |
|
a) |
Position/status |
Executive Vice Chairman |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 16,953 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Riad Mishlawi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Riad Mishlawi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 22,601 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Majda Labadi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Majda Labadi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 15,855 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Bassam Kanaan
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Bassam Kanaan |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 25,729 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Khalid Nabilsi
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Khalid Nabilsi |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 23,062 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Brian Hoffmann
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Brian Hoffmann |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Shares acquired from vesting of the conditional awards on |
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 18,247 |
d) |
Aggregated information |
N/A |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Hussein Arkhagha
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
Name |
Hussein Arkhagha |
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b) |
Initial notification /Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name |
Hikma Pharmaceuticals PLC |
b) |
LEI |
549300BNS685UXH4JI75 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
b) |
Nature of the transaction |
Disposal of Shares acquired from vesting of the conditional awards on 18 May 2020 under the 2014 EIP Element B. |
c) |
Price(s) and volume(s) |
Price(s): £24.629 Volume(s): 13,489 |
d) |
Aggregated information |
Aggregated volume: 13,489 Price: £332,220.58 |
e) |
Date of the transaction |
19 May 2020 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.